Pharmacokinetics of dexamethasone in premature neonates

European Journal of Clinical Pharmacology

Volumn 49, Issue 6, 1996, Pages 477-483

  Lugo, R A ^a,b   Nahata, M C ^a   Menke, J A ^a   McClead Jr , R E ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Bronchopulmonary dysplasia; Dexamethasone; Infant; Newborn; Pharmacokinetics; Premature neonates

Indexed keywords

DEXAMETHASONE;

AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG CLEARANCE; DRUG DISPOSITION; DRUG HALF LIFE; GESTATIONAL AGE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG DYSPLASIA; NEWBORN; PHARMACODYNAMICS; PHARMACOKINETICS; PREMATURE LABOR; PRIORITY JOURNAL;

EID: 0030003473     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00195934     Document Type: Article

References (30)

1. Avery GB, Fletcher AB, Kaplan M, Brudno DS (1985) Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75:106-111
2. Kazzi NJ, Brans YW, Poland RL (1990) Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics 86:722-727
3. Cummings JJ, D'Eugenio DB, Gross SJ (1989) A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 320:1505-1510
4. Harkavy KL, Scanlon JW, Chowdhry PK, Grylack LJ (1989) Dexamethasone therapy for chronic lung disease in ventilator-and oxygen-dependent infants: A controlled trial. J Pediatr 115:979-983
5. Ohlsson A, Calvert SA, Hosking M, Shennan AT (1989) Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilatory-dependent chronic lung disease. Ped Res 25:225A
6. Yeh TF, Torre JA, Rastofi A, Anyebuno MA, Pildes RS (1990) Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: A double-blind, controlled study. J Pediatr 117:273-282
7. Collaborative Dexamethasone Trial Group (1991) Dexamethasone therapy in neonatal chronic lung disease: An international placebo-controlled trial. Pediatrics 88:421-427
8. Ariagno RL, Sweeney TJ, Baldwin RB, Inguillo D, Martin D (1987) Dexamethasone effects on lung function in 3 week old ventilator dependent preterm infants. Am Rev Resp Dis 135:A125
9. Ferrara TB, Couser RJ, Hoekstra RE (1989) Side effects and long-term follow-up of corticosteroid therapy in very low birth-weight infants with bronchopulmonary dysplasia. J Perinatol 10:137-142
10. Wilson DM, Baldwin RB, Ariagno RL (1988) A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr 113:764-768
11. Cronin CMG, Dean H, MacDonald NT, Seshia MMK (1993) Basal and post-ACTH cortisol levels in preterm infants following treatment with dexamethasone. Clin Invest Med 16:8-14
12. Alkalay AL, Pomerance JJ, Pun AR, et al (1990) Hypothalamic-pituitary-adrenal axis function in very low birth-weight infants treated with dexamethasone. Pediatrics 86:204-210
13. Rizvi ZB, Aniol HS, Myers TF, Zeller WP, Fisher SG, Anderson CL (1992) Effects of dexamethasone on the hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr 120:961-965
14. Sauder SE, Powers WF, Wise JE (1987) Suppression of the pituitary-adrenal axis in very low birth weight infants after dexamethasone therapy for bronchopulmonary dysplasia. Clin Res 35:913A
15. Ng PC, Blackburn ME, Brownlee KG, Buckler JMH, Dear PR F (1989) Adrenal response in very low birthweight babies after dexamethasone treatment for bronchopulmonary dysplasia. Arch Dis Child 64:1721-1726
16. MacDonald PD, Galea P, Alroomi LG (1990) A catabolic state in dexamethasone treatment of bronchopulmonary dysplasia. Arch Dis Child 65:560-561
17. Brownlee KG, Ng PC, Henderson MJ, Smith M, Green JH, Dear PRF (1992) Catabolic effect of dexamethasone in the preterm baby. Arch Dis Child 67:1-4
18. Williams AF, Jones M (1992) Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia. Arch Dis Child 67:5-9
19. Hochhaus G, Hochhaus R, Werber G, Derendorf H (1992) A selective HPLC/RIA for dexamethasone and its prodrug dexamethasone-21-sulphobenzoate sodium in biologic fluids. Biomed Chromatogr 6:283-286
20. Morselli PL, Morselli RF, Bossi L (1980) Clinical pharmacokinetics in newborns and infants. Clin Pharmacokinet 5:485-527
21. Tsuei SE, Moore RG, Ashley JJ, McBride WG (1979) Disposition of synthetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults. J Pharmacokinet Biopharm 7:249-264
22. Eadie MJ, Brophy TR, Ohlrich G, Tyrer JH (1984) Dexamethasone: pharmacokinetics in neurological patients. Clin Exp Neurol 20:107-118
23. Charles B, Schild P, Steer P, Cartwright D, Donovan T (1993) Pharmacokinetics of dexamethasone following single-dose intravenous administration to extremely low birth weight infants. Dev Pharmacol Ther 20:205-210
24. Richter O, Reinhardt D, Becker B (1983) Pharmacokinetics of dexamethasone in children. Pediatr Pharmacol 3:329-337
25. Mammel MC, Johnson DE, Green T, Thompson TR (1983) Controlled trial of dexamethasone in infants with bronchopulmonary dysplasia. Lancet 1:1356-1357
26. Georgieff MK, Mammel MC, Mills MM, Gunter EW, Johnson DE, Thompson TR (1989) Effect of postnatal steroid administration on serum vitamin A concentrations in newborn infants with respiratory compromise. J Pediatr 114: 301-304
27. Britton MG, Collins JV, Brown D, Fairhurst NPA, Lambert RG (1976) High-dose corticosteroids in severe acute asthma. Br Med J 2:73
28. Ng PC (1993) The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 68:330-336
29. Meikle AW, Clarke DH, Tyler FH (1976) Gushing syndrome from low doses of dexamethasone. JAMA 235:1592-1593
30. Kozower M, Veatch L, Kaplan MM (1974) Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. J Clin Endocrinol Metab 38: 407-411